Nesopin 0.05% 10 ml nasal spray

Active ingredients Oxymetazoline

Country of originRussia

ManufacturerSintez JSC

Release form: 10 ml of the drug in polymer vials with a spray nozzle

Keep out of reach of children

Dosage form

Nasal spray

Structure

oxymetazoline hydrochloride - 0.5 mg

auxiliary substances: menthol, eucalyptus oil, disodium edetate, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, propylene glycol, benzyl alcohol, water for injection up to 1 ml.

general description

Alpha adrenomimetic

Special conditions

In the recommended dosage without consulting a doctor, you can use no more than

3 days.

Avoid getting the drug intended for intranasal administration in the eyes.

The drug affects vision (if it gets into the eyes), the reaction rate may decrease.

In excess of the recommended dosages, it may affect the ability to drive a vehicle or equipment.

Drug interactions

Slows down the absorption of local anesthetic drugs, lengthens their action.

The co-administration of other vasoconstrictor drugs increases the risk of side effects.

With the simultaneous appointment of monoamine oxidase blockers and tricyclic antidepressants - an increase in blood pressure.

Pharmacodynamics

Topical alpha adrenergic stimulant.

Has a vasoconstrictor effect.

With intranasal administration, the swelling of the mucous membrane of the upper respiratory tract decreases.

The action manifests itself 15 minutes after application and lasts for 8-12 hours.

Indications

Rhinitis of allergic and infectious-inflammatory etiology, sinusitis, eustachitis, hay fever.

A remedy for the treatment of the common cold.

Contraindications

Hypersensitivity, atrophic rhinitis, pregnancy, lactation, children (up to 6 years).

Overdose

Symptoms: tachycardia, increased blood pressure, depression of the central nervous system.

Treatment: symptomatic therapy is performed.

Side effects

Transient dryness and burning of the nasal mucosa, dry mouth and throat, sneezing

increased blood pressure, increased anxiety, nausea, dizziness, headache, insomnia, palpitations, sleep disturbances.

With prolonged use - tachyphylaxis, reactive hyperemia of the mucous membrane and atrophy of the mucous membrane of the nasal cavity.

Dosage

0.05% x 10ml

Indications

Rhinitis (allergic and infectious-inflammatory etiology)

sinusitis

eustachitis

hay fever.

Storage conditions and periods

In a dark place at a temperature of 15-25 degrees.

Expiration date: 2 years

INN / Active ingredient

Oxymetazoline

Contraindications

Atrophic rhinitis

pregnancy

lactation period (breastfeeding)

children under 6 years old

hypersensitivity to drug components.

Care should be taken to prescribe the drug for chronic heart failure, arrhythmias, severe atherosclerosis, arterial hypertension, thyrotoxicosis, diabetes mellitus, chronic renal failure, angle-closure glaucoma.

Specifications

Category

Runny nose

Scope of the drug

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Virology

Vacation conditions

Without recipe

Brand name

Synthesis

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant - alpha adrenergic agonist

Anatomical and therapeutic characteristics

R01AA05 Oxymetazoline

Dosage form

Nasal spray

Expiration date in days

730

Dosage (volume) of the substance in the preparation

oxymetazoline hydrochloride - 0.5 mg

Package weight, g

25